Advertisement

Topics

X4 Pharmaceuticals to Present Clinical Data from Phase 2 Study of X4P-001-RD in WHIM Syndrome

09:52 EDT 17 May 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Study designed to evaluate X4P-001-RD in a rare genetic, primary immunodeficiency disease to be presented at the Annual Congress of the European Hematology Association X4 Pharmaceuticals, a clinical stage biotechnolog...

Other Sources for this Article

X4 Pharmaceuticals
Kathryn Morris, 914-204-6412
kathryn@theyatesnetwork.com

NEXT ARTICLE

More From BioPortfolio on "X4 Pharmaceuticals to Present Clinical Data from Phase 2 Study of X4P-001-RD in WHIM Syndrome"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...